Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-23T14:03:56.887Z Has data issue: false hasContentIssue false
  • English
  • Français

Epidemiologia del farmaco in psichiatria

Published online by Cambridge University Press:  11 October 2011

Gianni Tognoni
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editoriali
Information
Epidemiology and Psychiatric Sciences , Volume 1 , Issue 3 , December 1992 , pp. 151 - 153
Copyright
Copyright © Cambridge University Press 1992

References

BIBLIOGRAFIA

Bergman, U., Grimsson, A., Wahba, A. H. W. & Westerholm, B. (ed.) (1979). Studies in Drug Utilization. Methods and Applications. WHO Regional Office for Europe: Copenhagen.Google Scholar
van Boxtel C., J. (ed.) (1991). Post Marketing Surveillance. Elsevier Science: Amsterdam.Google Scholar
de Girolamo, G., Williams, P. & Cappiello, V. (1987). Psychotropic drug utilization and audit in two Italian Psychiatric services. Psychological Medicina, 17, 989–997 (Vedi specificamente la Tabella comparativa degli studi pubblicati).CrossRefGoogle ScholarPubMed
Haayer-Ruskamp, F. M. & Dukes, M. N. G. (1986). Drugs and Money. A preliminary Survey and Research Proposal. WHO: Groningen (Disponibile come n. 53-54nei Quaderni di Sanita Pubblica, CSI: Milano).Google Scholar
Holm, M. & Olesen, F. (1988). Factors affecting prescription of psychotropic drugs in general practice. Scandinavian Journal of Primary Health Care 6, 169–173.CrossRefGoogle ScholarPubMed
Lawson, D.H. (1984). Pharmaco-epidemiology: a new discipline. British Medical Journal 289, 940–941.CrossRefGoogle Scholar
Lunde, P. K. M. (1992). L'uso razionale dei farmaci. Ricerca & Pratica 43, 24–36 (Traduzione diun testo ancora in press presentato nel Seminario Internazionale «Auditing Drug Therapy Approaches toward rationality at reasonable cost», Stoccolma, 1991).Google Scholar
Mann, R. (ed.) (1992). Pharmacoepidemiology and Drug Safety. John Wiley: West Sussex.Google Scholar
Medawar, C. (ed.) (1992). Power and Dependence. Social Audit on the safetyof medicines: London (Commentato per le implicazioni metodologiche sul significato di epidemiologia in Ricerca & Pratica 45, 92–98).Google Scholar
Montanaro, M., Magrini, N., Vaccheri, A. & Battilana, M. (1992). Drug utilization in general practice: prescribing habits of National Formulary drugs by GPs of Emilia Romanga (Italy) in 1988 and 1989. European Journal of Clinical Pharmacology 42, 401–408.CrossRefGoogle Scholar
Romero, M., Giambuzzi, M., Nigro, et al. (1991). DURG-I: una bibliografia e qualcosa di più. Giornale Italiano di Farmacia Clinica 5, 41–49.Google Scholar
Saraceno, B. (ed.) (1990). Uso Razionale degli Psicofarmaci. Farmacie Comunali Riunite: Reggio Emilia.Google Scholar
Terzian, E. & Tognoni, G. (1991). An epidemiological framework for essential drugs. ISDB Review 1, 19–24.Google Scholar
Tognoni, G. & Laporte, J.R. (ed.) (1984). Epidemiologia del Farmaco.II Pensiero Scientifico: Roma (Vedisoprattutto ilprimo capitolo pp. 1–33e I'ultimo capitolo pp. 157-169).Google Scholar
Tognoni, G. & Laporte, J.R. (1992). From clinical trials to drug utilization studies. In Drug Utilization Studies: Methods and Use. WHO: Copenhagen (in press).Google Scholar
Tognoni, G., Bellantuono, C. & Lader, M. (ed.) (1981). Epidemiological Impact of Psychotropic Drugs. Elsevier: Amsterdam.Google Scholar
Tognoni, G., Martini, N. & Del Fa vero, A. (1991). Appunti per ricordare giugno 1991. Giornale Italiano di Farmacia Clinica 5, 81–86.Google Scholar
Unità di, Psichiatria, Istituto di Ricerche Farmacologiche «Mario Negri» (1986-1992). Lettera. Percorsi Bibliograflci in Psichiatria, volumi I–XIII, 1986–1992 (Vedi soprattutto: volume IV, 1-27, 1987; volume XI, 1991, tutto).Google Scholar
Workshop on drug utilization review. Rockville, Maryland, November 26–27, 1990. Clinical Pharmacology & Therapeutics 50, Part 2, 1991.Google Scholar